Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-05-14 @ 2:51 AM
Study NCT ID:
NCT02773459
Status:
COMPLETED
Last Update Posted:
2019-09-30
First Post:
2016-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Sponsor:
Seoul National University Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Biliary Tract Cancer | View |
Keywords: